YTHDF1 and acute myeloid leukemia: YTHDF1 is implicated in driving tumorigenesis, with elevated YTHDF1 linked to poor outcomes in several cancer types including hepatocellular carcinoma, colorectal cancer, and acute myeloid leukemia (6–9).